Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1Phase 1 1

Status

Completed 2Terminated 1Recruiting 1

Sponsor Class

OTHER 21NIH 4NETWORK 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 4CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Leukemia 20Lymphoma 19Breast Neoplasms 19Burkitt Lymphoma 15Lymphoma, Large B-Cell, Diffuse 9Leukemia, Myeloid, Acute 9Myelodysplastic Syndromes 8Central Nervous System Neoplasms 8Lymphoma, Non-Hodgkin 7Anemia, Refractory, with Excess of Blasts 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Myelomonocytic, Chronic 6Hodgkin Disease 6Lymphoma, Follicular 5Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia, Biphenotypic, Acute 5Dendritic Cell Sarcoma, Interdigitating 5Acquired Immunodeficiency Syndrome 5Osteosarcoma 4Myeloproliferative Disorders 4Multiple Myeloma 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large-Cell, Anaplastic 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4HIV Infections 4Congenital Abnormalities 4

Interventions

X-Rays 7Specimen Handling 7Magnetic Resonance Spectroscopy 7Phantoms, Imaging 6Biopsy 5Nuclear Medicine Department, Hospital 4Methotrexate 4Doxorubicin 4cixutumumab 3cabozantinib 3Temozolomide 3Leucovorin 3Filgrastim 3Cyclophosphamide 3Cisplatin 3ulixertinib 2tipifarnib 2temsirolimus 2tazemetostat 2tanespimycin 2selpercatinib 2palbociclib 2olaparib 2merphos 2larotrectinib 2ixabepilone 2ivosidenib 2ensartinib 2dinutuximab 2Vemurafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
NIH × Osteosarcoma × Methotrexate × Clear all
NCT05691478 2026-06-03

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

National Cancer Institute (NCI)

Phase 2/3 Recruiting
1,122 enrolled
Sarcoma

Osteosarcoma

NCT00019864 2015-06-08

Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma

National Cancer Institute (NCI)

Phase 2 Terminated
100 enrolled
Sarcoma

Sarcoma, Osteosarcoma, Cardiotoxicity

NCT00513981 2013-06-26

High-Dose Methotrexate in Treating Young Patients With Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
36 enrolled
CNSSarcoma

Familial ependymoma, Sarcoma, Osteosarcoma, Central Nervous System Neoplasms

NCT00023998 2013-02-04

Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma

National Cancer Institute (NCI)

Phase 2 Completed
80 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡